Significant funding rounds are powering the next wave of innovation this week in MedTech - from brain-computer interfaces and muscle-computer tech to structural heart devices and continuous biosensing. Capital is enabling U.S. and global...
Significant funding rounds are powering the next wave of innovation this week in MedTech - from brain-computer interfaces and muscle-computer tech to structural heart...
Science Corporation announced that it closed an oversubscribed $230 million Series C financing round.
Lightspeed Venture Partners, Khosla Ventures, Y Combinator, IQT and Quiet Capital,...
Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...
Airiver Medical announced that it received FDA breakthrough device designation for its pulmonary drug-coated balloon (DCB).
Additionally, Airiver announced the first treated patients in a...
Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...
TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...
VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...
Kandu Health announced positive results from the first randomized controlled trial of its brain-computer interface (BCI) therapy.
The trial evaluated its FDA-cleared, non-invasive IpsiHand BCI...
Significant funding rounds are powering the next wave of innovation this week in MedTech - from brain-computer interfaces and muscle-computer tech to structural heart...
Science Corporation announced that it closed an oversubscribed $230 million Series C financing round.
Lightspeed Venture Partners, Khosla Ventures, Y Combinator, IQT and Quiet Capital,...
Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...
Airiver Medical announced that it received FDA breakthrough device designation for its pulmonary drug-coated balloon (DCB).
Additionally, Airiver announced the first treated patients in a...